Revere is the first-ever venture fund with a focus on oral health, bringing the best oral and systemic health start-ups and the brightest founders to market by matching them with exceptional investors and industry experts. With an intimate knowledge of the industry, and a proven track record, Revere can help foster unrivaled strategic partnerships that will improve care delivery, as well as patients’ and providers’ experiences — thereby maximizing value for investors. Investment Strategy: Our data and track record suggests that LP's who have invested in this space have done best with a 2:1 Series A:Seed ratio. We will have small allotments for special opportunities (pre-seed, innovation competitions) and follow on investments (Series B and beyond). We will seek Board seats where possible. Investment Targets: 1. Tech - Diagnostics 2. Dental Services - Biotech 3. Consumer - Brands 4. Payments - Reimbursement 5. Access to care Our thesis is three pronged: 1. Capital access. We are a strategic and active investor, a thought leader. We are not a service provider, incubator, accelerator, or venture studio. 2. Industry access. We have built an all star 25+ person team to connect startups with leadership at the top dental chains, manufacturers, distributors, insurers, academics, professional associations, nationwide labs, and retailers. 3. Insights. We conducted a 20 month research project leading to a first of its kind publishable paper proving the strong return profile of early stage oral health investments. We plan to bring awareness and education to elevate dental investments. The facts: 1. There is $180bn spent on oral care delivery in the US per year, accounting for roughly 4% of healthcare spending. 2. Approximately 8% of all VC deals are on healthcare, including oral health, and have been increasing over the last 10 years. 3. Oral care startups are under invested in compared to the market size, leaving room for opportunity to capture market share. 4. On an annual return basis, oral care startups have a 33% IRR, and even outperform PE investments in dental practices, PE acquisitions of late stage products, public dental equities, and the single practice when risk adjusted. We welcome investors from inside and outside of the oral care and healthcare industries to join us in the strong returns and elevating oral care across!